These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2891317)

  • 1. Treatment of allergic rhinoconjunctivitis in Denmark.
    Laursen LC
    Allergy; 1987 Oct; 42(7):556-7. PubMed ID: 2891317
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis.
    Panayotopoulos SM; Panayotopoulou ES
    Ann Allergy; 1990 Aug; 65(2):146-8. PubMed ID: 1974401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihistamines in rhinoconjunctivitis.
    Howarth P
    Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of a new topical anti-histamine agent histimet in the treatment of seasonal allergic rhinoconjunctivitis].
    Bulycheva NA; Ekinova GM; Vasil'eva TG
    Vestn Otorinolaringol; 1998; (3):46-8. PubMed ID: 9662981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in H1-antihistamines.
    Simons FE
    N Engl J Med; 2004 Nov; 351(21):2203-17. PubMed ID: 15548781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the treatment of various allergic diseases using a new histamine and serotonin antagonist bicarphene].
    Goriachkina LA; Poroshina IuA; Semenova GIa; Kaminka ME; Absava GI; Mashkovskiĭ MD
    Klin Med (Mosk); 1990 May; 68(5):84-7. PubMed ID: 1975846
    [No Abstract]   [Full Text] [Related]  

  • 8. Loderix (setastine) tablets in the treatment of allergic rhinoconjunctivitis.
    Lantos A; Tóth A; Zsiray M
    Ther Hung; 1991; 39(1):22-4. PubMed ID: 1677500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of allergic rhinoconjunctivitis in Denmark].
    Laursen LC
    Ugeskr Laeger; 1987 Nov; 149(48):3278-9. PubMed ID: 3433532
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergic rhinitis: a study on the prescribing preferences in general practice.
    Jones HS
    Br J Clin Pract; 1989 Jan; 43(1):30-2. PubMed ID: 2480154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M; Pipkorn U
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and safety of levocarbastine++ in the therapy in children suffering from seasonal allergic rhinitis and conjunctivitis who are less than 12 year of age].
    Kurzawa R; Kossek M; Doniec Z; Mazurek H; Urbanek E; Sak-Kopytyńska I; Radliński J; Bukowczan Z
    Pol Merkur Lekarski; 1998 May; 4(23):269-72. PubMed ID: 9825660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical therapeutics: the use of histamine receptor antagonists in contemporary times.
    Obel AO
    East Afr Med J; 1984 Jul; 61(7):578-82. PubMed ID: 6152737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of astemizole. A survey of 50 double-blind trials.
    Vanden Bussche G; Emanuel MB; Rombaut N
    Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test.
    Pécoud A; Zuber P; Kolly M
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):541-3. PubMed ID: 2883132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal corticosteroids and the eye: from negative ocular effects to clinical efficacy as a class effect.
    Bielory L
    Ann Allergy Asthma Immunol; 2008 May; 100(5):506-8. PubMed ID: 18517085
    [No Abstract]   [Full Text] [Related]  

  • 20. Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study).
    Bachert C; Vovolis V; Margari P; Murrieta-Aguttes M; Santoni JP
    Allergy; 2001 Jul; 56(7):653-9. PubMed ID: 11421924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.